TY - JOUR
T1 - Deterioration of Glycemic Control in Youth-Onset Type 2 Diabetes
T2 - What Are the Early and Late Predictors?
AU - Zeitler, Philip
AU - El Ghormli, Laure
AU - Arslanian, Silva
AU - Caprio, Sonia
AU - Isganaitis, Elvira
AU - Kelsey, Megan K.
AU - Weinstock, Ruth S.
AU - White, Neil H.
AU - Drews, Kimberly
N1 - Funding Information:
Funding Support. This work was completed with funding from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) and the NIH Office of the Director (OD) through grants U01-DK61212, U01-DK61230, U01-DK61239, U01-DK61242, and U01-DK61254; from the National Center for Research Resources General Clinical Research Centers Program grant numbers M01-RR00036 (Washington University School of Medicine), M01-RR00043-45 (Children’s Hospital Los Angeles), M01-RR00069 (University of Colorado Denver), M01-RR00084 (Children’s Hospital of Pittsburgh), M01-RR01066 (Massachusetts General Hospital), M01-RR00125 (Yale University), and M01-RR14467 (University of Oklahoma Health Sciences Center); and from the NCRR Clinical and Translational Science Awards grant numbers UL1-TR000003 (Children’s Hospital of Philadelphia), UL1-TR001863 (Yale University), UL1-TR001857 (Children’s Hospital of Pittsburgh), UL1-TR002548 (Case Western Reserve University), UL1-TR002345 (Washington University in St Louis), UL1-TR002541 (Massachusetts General Hospital), and UL1-TR002535 (University of Colorado Denver). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.
Publisher Copyright:
© 2022 Endocrine Society. All rights reserved.
PY - 2022/8/1
Y1 - 2022/8/1
N2 - Objective: We examined predictors of early and late loss of glycemic control in individuals with youth-onset type 2 diabetes, as well as predictors of short-term deterioration in youth from the Treatment Options for type 2 Diabetes in Adolescents and Youth (TODAY) study. Methods: Demographic, physical, and biochemical measures at baseline and 48 months, and change over time, were examined in 584 participants separated into those with loss of glycemic control (sustained HbA1c ≥ 8%) before 48 months or at 48 months or later, and those who remained in control until the end of the study (median 6.8 years). Univariate and multivariate models, and receiver operating characteristic curve analyses were performed. Results: Approximately 45% of youth remained in control at 48 months; of these, 30% subsequently lost glycemic control prior to the end of follow-up. Predictors of early loss of glycemic control included baseline HbA1c, C-peptide index, oral disposition index, proinsulin, and proinsulin to insulin ratio. Predictors of late loss included baseline measures of insulin secretion and change in HbA1c and insulin processing at 48 months. A baseline HbA1c cutoff of ≥ 6.2% was optimally predictive of loss of glycemic control at any time, while an absolute rise in HbA1c >0.5% related to loss of glycemic control within 3 to 6 months. Conclusion: This analysis demonstrates that youth with type 2 diabetes at risk for loss of glycemic control, including impending rapid deterioration, can be identified using available clinical measures, allowing for closer monitoring of at-risk youth, and facilitating the design of research on better therapeutic options.
AB - Objective: We examined predictors of early and late loss of glycemic control in individuals with youth-onset type 2 diabetes, as well as predictors of short-term deterioration in youth from the Treatment Options for type 2 Diabetes in Adolescents and Youth (TODAY) study. Methods: Demographic, physical, and biochemical measures at baseline and 48 months, and change over time, were examined in 584 participants separated into those with loss of glycemic control (sustained HbA1c ≥ 8%) before 48 months or at 48 months or later, and those who remained in control until the end of the study (median 6.8 years). Univariate and multivariate models, and receiver operating characteristic curve analyses were performed. Results: Approximately 45% of youth remained in control at 48 months; of these, 30% subsequently lost glycemic control prior to the end of follow-up. Predictors of early loss of glycemic control included baseline HbA1c, C-peptide index, oral disposition index, proinsulin, and proinsulin to insulin ratio. Predictors of late loss included baseline measures of insulin secretion and change in HbA1c and insulin processing at 48 months. A baseline HbA1c cutoff of ≥ 6.2% was optimally predictive of loss of glycemic control at any time, while an absolute rise in HbA1c >0.5% related to loss of glycemic control within 3 to 6 months. Conclusion: This analysis demonstrates that youth with type 2 diabetes at risk for loss of glycemic control, including impending rapid deterioration, can be identified using available clinical measures, allowing for closer monitoring of at-risk youth, and facilitating the design of research on better therapeutic options.
KW - glycemic control
KW - risk factors
KW - type 2 diabetes
KW - youth
UR - http://www.scopus.com/inward/record.url?scp=85134428199&partnerID=8YFLogxK
U2 - 10.1210/clinem/dgac254
DO - 10.1210/clinem/dgac254
M3 - Article
C2 - 35486388
AN - SCOPUS:85134428199
SN - 0021-972X
VL - 107
SP - E3384-E3394
JO - Journal of Clinical Endocrinology and Metabolism
JF - Journal of Clinical Endocrinology and Metabolism
IS - 8
ER -